GL1X · GenesisL1 explorer

MolNFT v1 · #50399 · protein

Actinorhodin ketoreductase, actkr, with NADPH and inhibitor emodin

2RH4 · Actinorhodin polyketide ketoreductase: “Actinorhodin ketoreductase, actkr, with NADPH and inhibitor emodin”. X-ray diffraction, 2 ligands (NDP, EMO), 3 pockets (best druggability 0.78). MolNFT v1 #50399 on GenesisL1: 3D structure…

PDB
2RH4
Type
protein
Length
525 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Actinorhodin polyketide ketoreductase
EC
1.3.1.-
UniProt
P16544
Ligands
NDP, EMO
Pockets
3 · best druggability 0.78

Structure

x-ray diffraction · 2 distinct chains · 50% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AActinorhodin polyketide ketoreductase (EC 1.3.1.-)protein25749% helix, 14% strandP16544
BActinorhodin polyketide ketoreductase (EC 1.3.1.-)protein26850% helix, 16% strandP16544

Ligands and binding sites

  • NDP · Nadph dihydro-nicotinamide-adenine-dinucleotide phosphate · ligand · 2 copies · chains A, B
  • EMO · 3-methyl-1,6,8-trihydroxyanthraquinone · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15320.780.8559NDP
26090.730.8054NDP, EMO
3690.390.7914empty

Interfaces

1 interface between chains.

  • A–B · 1637 Ų buried · 18 hydrogen bonds · protein-protein

Compared structures

  • 2RH4 · Actinorhodin ketoreductase, actKR, with NADPH and Inhibitor Emodin · the same entry in another collection · chain A against A, TM-score 1.00
  • P16544 · AlphaFold monomer V2.0 prediction for putative ketoacyl reductase (P16544) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.